Does cosmetic use mean GHK-Cu is approved?

As a cosmetic ingredient, within that framework. It carries no implication of medicinal approval, which is assessed entirely separately.

Can a cosmetic claim to repair skin?

Not therapeutically. Cosmetics may make appearance claims; treating, curing or preventing anything is a medicinal claim under a different framework.

What Is Copper Tripeptide-1?

The short answer

Copper tripeptide-1 is the INCI name for GHK-Cu, the standardised nomenclature used to declare ingredients on cosmetic labels. It is the same molecule under a different naming system, but the framework regulating it as a cosmetic ingredient is entirely separate from medicines regulation.

Key facts

INCI name: Copper tripeptide-1
Same as: GHK-Cu
Naming system: International Nomenclature of Cosmetic Ingredients
Framework: Cosmetics regulation, not medicines
Implies: Permitted in cosmetic products
Does not imply: Medicinal approval of any kind

What INCI is for

The International Nomenclature of Cosmetic Ingredients gives every cosmetic ingredient one standardised name so that labels are comparable across products and jurisdictions. It is a naming convention with a regulatory function (allowing consumers and regulators to identify what is in a product) and nothing more.

Why the same molecule has two names

Chemistry, medicine and cosmetics each maintain their own nomenclature. The same substance is glycyl-L-histidyl-L-lysine copper to a chemist, prezatide in generic drug naming, and copper tripeptide-1 on a cosmetic label. None of these is more correct than the others; they belong to different systems built for different purposes.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £24.99

The distinction that actually matters

Cosmetics and medicines are regulated under separate frameworks with different requirements. A cosmetic is regulated on safety and on the claims it makes about appearance; a medicine requires demonstrated efficacy and safety for a therapeutic claim, assessed by a regulator. An ingredient being permitted in cosmetics says nothing whatsoever about medicinal approval, and the two should never be conflated.

Why this matters for research material

The existence of copper tripeptide-1 in cosmetic products creates a tempting but false inference: that GHK-Cu is therefore an approved or established substance. It is approved as a cosmetic ingredient. Material supplied for laboratory research is neither a cosmetic product nor a medicine, and its status is unaffected by cosmetic regulation.

The claims difference

A cosmetic may make appearance claims within defined limits. It may not claim to treat, cure or prevent anything; the moment it does, it is making a medicinal claim and falls under a different framework. That boundary is the same one governing research material, which is why this library describes mechanisms and studies rather than outcomes.

Frequently asked questions

Does cosmetic use mean GHK-Cu is approved?: As a cosmetic ingredient, within that framework. It carries no implication of medicinal approval, which is assessed entirely separately.
Can a cosmetic claim to repair skin?: Not therapeutically. Cosmetics may make appearance claims; treating, curing or preventing anything is a medicinal claim under a different framework.

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically. Nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses, including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

▸In vitro fibroblast and keratinocyte gene-expression studies
▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
▸Wound-healing scratch assays in cell culture models
▸Antioxidant-mechanism studies (copper redox modulation)
▸Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

✓Store lyophilised vial at 2–8 °C, protected from light
✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
✓Aliquot reconstituted solution for freeze/thaw minimisation
✓Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

✗ Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex, keep them separate.

✗ Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

How we write and check this content Report a factual error in this article

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category.

← Back to Forum

Copper Tripeptide-1: The Cosmetic Ingredient Name